<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/">
  <channel>
    <title>Results for Riccardi, Ferdinando</title>
    <description>Showing 1 - 24 results of 24</description>
    <generator>Laminas_Feed_Writer 2 (https://getlaminas.org)</generator>
    <link>https://buscaintegrada.ufrj.br/Author/?sort=last_indexed+desc&amp;limit=50&amp;author=%22Riccardi%2C+Ferdinando%22&amp;type=Author</link>
    <opensearch:totalResults>24</opensearch:totalResults>
    <opensearch:startIndex>0</opensearch:startIndex>
    <opensearch:itemsPerPage>50</opensearch:itemsPerPage>
    <opensearch:Query role="request" searchTerms="%22Riccardi%2C%20Ferdinando%22" startIndex="0"/>
    <atom:link rel="first" type="application/rss+xml" href="https://buscaintegrada.ufrj.br/Author/?sort=last_indexed+desc&amp;limit=50&amp;view=rss&amp;author=%22Riccardi%2C+Ferdinando%22&amp;type=Author"/>
    <atom:link rel="last" type="application/rss+xml" href="https://buscaintegrada.ufrj.br/Author/?sort=last_indexed+desc&amp;limit=50&amp;view=rss&amp;author=%22Riccardi%2C+Ferdinando%22&amp;type=Author"/>
    <atom:link rel="self" type="application/rss+xml" href="https://buscaintegrada.ufrj.br/Author/?sort=last_indexed+desc&amp;limit=50&amp;view=rss&amp;author=%22Riccardi%2C+Ferdinando%22&amp;type=Author"/>
    <item>
      <title>Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer</title>
      <pubDate>Fri, 01 Jan 2010 23:44:51 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-2825189</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-2825189</guid>
      <author>Riccardi, Ferdinando</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2010</dc:date>
      <dc:creator>Riccardi, Ferdinando</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study</title>
      <pubDate>Sun, 01 Jan 2012 23:44:51 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-3433340</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-3433340</guid>
      <author>Clavarezza, Matteo</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2012</dc:date>
      <dc:creator>Clavarezza, Matteo</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey</title>
      <pubDate>Tue, 01 Jan 2013 23:44:51 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-3810275</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-3810275</guid>
      <author>Silvestris, Nicola</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2013</dc:date>
      <dc:creator>Silvestris, Nicola</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Pancreatic solitary and synchronous metastasis from breast cancer: a case report and systematic review of controversies in diagnosis and treatment</title>
      <pubDate>Wed, 01 Jan 2014 23:44:51 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-3895687</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-3895687</guid>
      <author>Molino, Carlo</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2014</dc:date>
      <dc:creator>Molino, Carlo</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Erlotinib-induced complete response in a patient with epidermal growth factor receptor wild-type lung adenocarcinoma after chemotherapy failure: a case report</title>
      <pubDate>Wed, 01 Jan 2014 23:44:51 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-3978081</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-3978081</guid>
      <author>Vitale, Maria Giuseppa</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2014</dc:date>
      <dc:creator>Vitale, Maria Giuseppa</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Real-World Study of Everolimus in Advanced Progressive Neuroendocrine Tumors</title>
      <pubDate>Wed, 01 Jan 2014 23:44:51 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-4153458</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-4153458</guid>
      <author>Panzuto, Francesco</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2014</dc:date>
      <dc:creator>Panzuto, Francesco</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Natural History of Malignant Bone Disease in Hepatocellular Carcinoma: Final Results of a Multicenter Bone Metastasis Survey</title>
      <pubDate>Wed, 01 Jan 2014 23:44:51 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-4149423</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-4149423</guid>
      <author>Santini, Daniele</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2014</dc:date>
      <dc:creator>Santini, Daniele</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Real-World Study of Everolimus in Advanced Progressive Neuroendocrine Tumors</title>
      <pubDate>Thu, 01 Jan 2015 23:44:51 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-4425385</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-4425385</guid>
      <author>Panzuto, Francesco</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2015</dc:date>
      <dc:creator>Panzuto, Francesco</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Somatostatin Analogues according to Ki67 index in neuroendocrine tumours: an observational retrospective-prospective analysis from real life</title>
      <pubDate>Thu, 01 Jan 2015 23:44:51 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-4868704</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-4868704</guid>
      <author>Faggiano, Antongiulio</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2015</dc:date>
      <dc:creator>Faggiano, Antongiulio</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting</title>
      <pubDate>Sun, 01 Jan 2017 23:44:51 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-5469582</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-5469582</guid>
      <author>Generali, Daniele</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2017</dc:date>
      <dc:creator>Generali, Daniele</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)</title>
      <pubDate>Sun, 01 Jan 2017 23:44:51 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-5519815</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-5519815</guid>
      <author>Orditura, Michele</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2017</dc:date>
      <dc:creator>Orditura, Michele</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis</title>
      <pubDate>Sun, 01 Jan 2017 23:44:51 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-5762553</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-5762553</guid>
      <author>De Angelis, Carmine</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2017</dc:date>
      <dc:creator>De Angelis, Carmine</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safety</title>
      <pubDate>Mon, 01 Jan 2018 23:44:51 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-6109668</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-6109668</guid>
      <author>Riccardi, Ferdinando</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2018</dc:date>
      <dc:creator>Riccardi, Ferdinando</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Incidental finding of non-Hodgkin's lymphoma in a patient affected by castration-sensitive prostate cancer: A case report</title>
      <pubDate>Tue, 01 Jan 2019 23:44:51 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-6426560</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-6426560</guid>
      <author>Pirozzi, Angelo</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2019</dc:date>
      <dc:creator>Pirozzi, Angelo</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract: A case report</title>
      <pubDate>Tue, 01 Jan 2019 23:44:51 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-6708809</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-6708809</guid>
      <author>Pirozzi, Angelo</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2019</dc:date>
      <dc:creator>Pirozzi, Angelo</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Is There Still a Role for Endocrine Therapy Alone in HR+/HER2– Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies</title>
      <pubDate>Wed, 01 Jan 2020 23:44:51 -0300</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-7098305</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-7098305</guid>
      <author>Cazzaniga, Marina Elena</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2020</dc:date>
      <dc:creator>Cazzaniga, Marina Elena</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Second line trastuzumab emtansine following horizontal dual blockade in a real-life setting</title>
      <pubDate>Wed, 01 Jan 2020 23:44:51 -0300</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-7275781</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-7275781</guid>
      <author>Prete, Salvatore Del</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2020</dc:date>
      <dc:creator>Prete, Salvatore Del</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy</title>
      <pubDate>Wed, 01 Jan 2020 23:44:51 -0300</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-7288011</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-7288011</guid>
      <author>Vitale, Maria Giuseppa</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2020</dc:date>
      <dc:creator>Vitale, Maria Giuseppa</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Perioperative Chemotherapy in Poorly Differentiated Neuroendocrine Neoplasia of the Bladder: A Multicenter Analysis</title>
      <pubDate>Wed, 01 Jan 2020 23:44:51 -0300</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-7290869</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-7290869</guid>
      <author>Lamberti, Giuseppe</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2020</dc:date>
      <dc:creator>Lamberti, Giuseppe</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)</title>
      <pubDate>Wed, 01 Jan 2020 23:44:51 -0300</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-7341887</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-7341887</guid>
      <author>Gelsomino, Francesco</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2020</dc:date>
      <dc:creator>Gelsomino, Francesco</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus</title>
      <pubDate>Wed, 01 Jan 2020 23:44:51 -0300</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-7379869</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-7379869</guid>
      <author>Sciammarella, Concetta</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2020</dc:date>
      <dc:creator>Sciammarella, Concetta</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Folinic acid in colorectal cancer: esquire or fellow knight? Real-world results from a mono institutional, retrospective study</title>
      <pubDate>Fri, 01 Jan 2021 23:44:51 -0300</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-7869580</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-7869580</guid>
      <author>Romano, Francesco Jacopo</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2021</dc:date>
      <dc:creator>Romano, Francesco Jacopo</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Poorly Differentiated Neuroendocrine Larynx Carcinoma: Clinical Features and miRNAs Signature—A New Goal for Early Diagnosis and Therapy?</title>
      <pubDate>Fri, 01 Jan 2021 23:44:51 -0300</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-8125889</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-8125889</guid>
      <author>Ricciardiello, Filippo</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2021</dc:date>
      <dc:creator>Ricciardiello, Filippo</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)</title>
      <pubDate>Fri, 01 Jan 2021 23:44:51 -0300</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-8292309</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-8292309</guid>
      <author>Gelsomino, Francesco</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2021</dc:date>
      <dc:creator>Gelsomino, Francesco</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
  </channel>
</rss>
